Top 3 Health Care Stocks Which Could Rescue Your Portfolio In July
Top 3 Health Care Stocks Which Could Rescue Your Portfolio In July
7月份可以拯救你投资组合的前三家医疗保健股票
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. `
医疗保健板块中最超卖的股票提供了买入低估公司的机会。`
The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro.
RSI指标是一种动量指标，它比较了股票在价格上涨时的强度与在价格下跌时的强度。与股票的价格走势进行比较，可以给交易者更好的了解股票短期内表现的良好程度。当RSI低于30时，资产通常被认为是超卖的，根据Benzinga Pro的数据。
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
以下是本行业板块最近的主要超卖股票列表，RSI接近或低于30。
Aslan Pharmaceuticals Ltd (NASDAQ:ASLN)
纳斯达克上的aslan pharmaceuticals
- On July 17, ASLAN Pharmaceuticals announced that its Singapore-incorporated, sole operating subsidiary has filed for voluntary liquidation. The company said this decision was made following a thorough review of ASLAN SG's financial situation and strategic options. The company's stock fell around 69% over the past five days and has a 52-week low of $0.48.
- RSI Value: 25.34
- ASLN Price Action: Shares of Aslan Pharmaceuticals fell 37% to close at $0.70 on Wednesday.
- Benzinga Pro's real-time newsfeed alerted to latest Aslan Pharmaceuticals news.
- 7月17日，ASLAN Pharmaceuticals宣布，其在新加坡注册的唯一运营子公司已申请自愿清算。公司称，这一决定是在全面审查ASLAN SG的财务状况和战略选择后做出的。该公司的股票在过去5天内下跌约69％，52周低点为0.48美元。
- 相对强弱指数值：25.34
- aslan pharmaceuticals的股价表现：周三下跌37％，收盘价为0.70美元。
- Benzinga Pro的实时资讯提醒了最新的aslan pharmaceuticals资讯。
CERo Therapeutics Holdings Inc (NASDAQ:CERO)
CERo Therapeutics Holdings Inc（纳斯达克：CERO）
- On June 13, the company executed pre-IND manufacturing activities for its lead therapeutic, CER-1236. The company's stock fell around 33% over the past month. It has a 52-week low of $0.16.
- RSI Value: 20.79
- CERO Price Action: Shares of CERo Therapeutics gained 6.2% to close at $0.21 on Wednesday.
- Benzinga Pro's charting tool helped identify the trend in CERO stock.
- 6月13日，该公司为其主导治疗CER-1236执行了IND前制造活动。该公司的股票在过去一个月中下跌约33％。它的52周低点为0.16美元。
- 相对强弱指数值：20.79
- CERo Therapeutics的股价表现：周三上涨6.2％，收盘价为0.21美元。
- Benzinga Pro的图表工具有助于识别CERO股票的趋势。
Organovo Holdings Inc (NASDAQ:ONVO)
Organovo Holdings Inc（纳斯达克：ONVO）
- On July 16, Organovo presented the company's outlook and plans at Jones Trading Healthcare Conference. The company's stock dipped around 18% over the past five days and has a 52-week low of $0.55.
- RSI Value: 20.53
- ONVO Price Action: Shares of Organovo fell 5.2% to close at $0.59 on Wednesday.
- Benzinga Pro's signals feature notified of a potential breakout in Organovo shares.
- 7月16日，Organovo在Jones Trading Healthcare Conference上呈现了公司的展望和计划。该公司的股票在过去5天内下跌约18％，52周低点为0.55美元。
- 相对强弱指数值：20.53
- Organovo的股价表现：周三下跌5.2％，收盘价为0.59美元。
- Benzinga Pro的信号功能通知了Organovo股票潜在的突破信号。
- Jim Cramer Says Don't Sell Match Group: 'You've Just Got A Very, Very Smart Investor In There'
- 吉姆·克雷默说不要卖出Match Group：'你在那里只有一个非常聪明的投资者'